Jing Tang Stasis Breaker: Veterinary Product Profile

Jing Tang Stasis Breaker is a named herbal formula for Dogs and cats; the current manufacturer page also lists horses; manufacturer positioning must be kept separate from independent clinical evidence.

Concentrated powder, capsules, tincture, non-concentrated powder, and teapills; excipients vary by presentation. Intended species: Dogs and cats; the current manufacturer page also lists horses.

Bai Hua She She Cao; Ban Zhi Lian; E Zhu; Mu Li (Shu); San Leng; Zhe Bei Mu. Inactive ingredients may include gluten-free maltodextrin, bovine gelatin, activated carbon, botanical wax, whitefish flavoring, or vegetable glycerin depending on presentation.

The manufacturer presents the formula through Traditional Chinese Veterinary Medicine language: breaking Blood stasis, softening hardness, clearing enlargement, promoting circulation, and supporting animals with abnormal masses. The official sales channel requires veterinary authorization.

May be discussed only as adjunctive/supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive goal, objective review date, adverse-effect plan, and stopping rule with the veterinarian.

Bring the current label, lot, complete ingredient panel, seller and country version, and every medicine and supplement to the treating veterinarian.

The reviewed official material documents the formula, presentations, traditional rationale, and authorization requirement, but it does not establish tumor shrinkage, delayed progression, or longer survival in a controlled canine or feline clinical trial of this finished product. Ingredient or TCVM tradition must not be converted into a product-level efficacy conclusion.

Formula selection should be made by a veterinarian trained in the relevant modality. The manufacturer notes possible digestive upset and advises contacting a veterinarian for vomiting, diarrhea, or allergic reactions. Presentation-specific excipients matter, particularly fish flavor, gelatin, and maltodextrin. A complete medication and supplement list should be reviewed because a current comprehensive interaction study for the finished formula was not located.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Sold through the current U.S. official channel as a veterinary herbal product requiring veterinary authorization. No FDA approval as a new animal drug was identified. Authorization imposed by a seller or manufacturer is not the same as FDA approval or evidence of anticancer efficacy.

United States

Record the exact presentation, lot, label, start date, intended supportive goal, appetite, stool, vomiting, skin changes, energy, body weight, and any change in the mass already being measured by the oncology team. Imaging, cytology, histopathology, staging, and prescribed monitoring continue on their own schedule; an herb response must not be inferred from touch alone.